Antibiotic efficacy in vivo predicted by in vitro activity

被引:15
|
作者
Mattie, H [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
关键词
in vitro; in vivo; E-max;
D O I
10.1016/S0924-8579(99)00145-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A brief overview of arguments found in the literature is presented to apply the E-max concept to experimental studies of antibiotics as well as to their clinical application. It may turn out to be more flexible than schedules based on arbitrary parameters that have the disadvantage that they have to be proven in each individual situation. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [31] In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth
    Sarojini Adusumilli
    Shelley E. Haydel
    BMC Complementary and Alternative Medicine, 16
  • [32] A synthetic segment of surfactant protein A: Structure, in vitro surface activity, and in vivo efficacy
    Walther, FJ
    DavidCu, R
    Leung, C
    Bruni, R
    HernandezJuviel, J
    Gordon, LM
    Waring, AJ
    PEDIATRIC RESEARCH, 1996, 39 (06) : 938 - 946
  • [33] In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth
    Adusumilli, Sarojini
    Haydel, Shelley E.
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 16
  • [34] In vitro oxidative activity of cupric complexes of kanamycin A in comparison to in vivo bactericidal efficacy
    Szczepanik, W
    Dworniczek, E
    Ciesiolka, J
    Wrzesinski, J
    Skala, J
    Jezowska-Bojczuk, M
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 94 (04) : 355 - 364
  • [35] In vitro activity and in vivo efficacy of fexinidazole against New World Leishmania species
    de Morais-Teixeira, Eliane
    Rabello, Ana
    Gontijo Aguiar, Marta Marques
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (08) : 2318 - 2325
  • [36] New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection
    Revest, M.
    Jacqueline, C.
    Boudjemaa, R.
    Caillon, J.
    Le Mabecque, V.
    Breteche, A.
    Steenkeste, K.
    Tattevin, P.
    Potel, G.
    Michelet, C.
    Fontaine-Aupart, M. P.
    Boutoille, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (05) : 1291 - 1299
  • [37] Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo
    Suzaki, H
    Asano, K
    Ohki, S
    Kanai, K
    Mizutani, T
    Hisamitsu, T
    MEDIATORS OF INFLAMMATION, 1999, 8 (4-5) : 199 - 204
  • [38] ANTIASTHMATIC ACTIVITY OF A MACROLIDE ANTIBIOTIC, ROXITHROMYCIN - ANALYSIS OF POSSIBLE MECHANISMS IN-VITRO AND IN-VIVO
    KONNO, S
    ASANO, K
    KUROKAWA, M
    IKEDA, K
    OKAMOTO, K
    ADACHI, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 105 (03) : 308 - 316
  • [39] MARIDOMYCIN, A NEW MACROLIDE ANTIBIOTIC .3. IN-VITRO AND IN-VIVO ANTIBACTERIAL ACTIVITY
    KONDO, M
    OISHI, T
    ISHIFUJI, K
    TSUCHIYA, K
    JOURNAL OF ANTIBIOTICS, 1973, 26 (04): : 206 - 214
  • [40] Antibiotic-loaded nanoparticles for the treatment of intracellular methicillin-resistant Staphylococcus Aureus infections: In vitro and in vivo efficacy of a novel antibiotic
    Costabile, Gabriella
    Baldassi, Domizia
    Mueller, Christoph
    Gross, Birgit
    Ungaro, Francesca
    Schubert, Soeren
    Firestine, Steven M.
    Merkel, Olivia M.
    JOURNAL OF CONTROLLED RELEASE, 2024, 374 : 454 - 465